RSV is a labile paramyxovirus that produces a characteristic fusion of human cells in tissue culture--the syncytial effect. Two subtypes, A and B, have been identified. Subtype B are characterized as the asymptomatic strains of the virus. The more severe clinical illnesses involve Subtype A strains.
Synonyms: RSV
Application: This Anti-RSV Antibody, fusion protein, all type A, B strains, clone 133-1H is validated for use in ELISA, IF for the detection of Respiratory Syncytial Virus.
Legal Information: CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Other Notes: Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.